Minnesota Oncology Hematology PA — Saint Paul, Minnesota

Minnesota Oncology Hematology PA is a clinical research site located in Saint Paul, Minnesota, United States 55102.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Minnesota Oncology Hematology PA has participated in 3 clinical trials.

Therapeutic areas: HER2 Positive Breast Cancer, Relapsed or Refractory Multiple Myeloma, Melanoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Amgen.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology Hematology PA?

Minnesota Oncology Hematology PA has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology Hematology PA conducted?

Minnesota Oncology Hematology PA has 3 clinical trials on record. Their work covers HER2 Positive Breast Cancer, Relapsed or Refractory Multiple Myeloma, Melanoma.

Is Minnesota Oncology Hematology PA accredited by Crixeo Health?

Minnesota Oncology Hematology PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Oncology Hematology PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.